182 related articles for article (PubMed ID: 20547482)
1. TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption.
Chamoux E; Bisson M; Payet MD; Roux S
J Biol Chem; 2010 Aug; 285(33):25354-62. PubMed ID: 20547482
[TBL] [Abstract][Full Text] [Related]
2. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
Masuyama R; Vriens J; Voets T; Karashima Y; Owsianik G; Vennekens R; Lieben L; Torrekens S; Moermans K; Vanden Bosch A; Bouillon R; Nilius B; Carmeliet G
Cell Metab; 2008 Sep; 8(3):257-65. PubMed ID: 18762026
[TBL] [Abstract][Full Text] [Related]
3. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.
Komarova SV; Pereverzev A; Shum JW; Sims SM; Dixon SJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2643-8. PubMed ID: 15695591
[TBL] [Abstract][Full Text] [Related]
4. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
Chen F; Ouyang Y; Ye T; Ni B; Chen A
J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765
[TBL] [Abstract][Full Text] [Related]
5. Calcium signaling in osteoclast differentiation and bone resorption.
Kajiya H
Adv Exp Med Biol; 2012; 740():917-32. PubMed ID: 22453976
[TBL] [Abstract][Full Text] [Related]
6. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations.
Kajiya H; Okamoto F; Nemoto T; Kimachi K; Toh-Goto K; Nakayana S; Okabe K
Cell Calcium; 2010 Nov; 48(5):260-9. PubMed ID: 20980052
[TBL] [Abstract][Full Text] [Related]
7. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
Ang ES; Yang X; Chen H; Liu Q; Zheng MH; Xu J
FEBS Lett; 2011 Sep; 585(17):2755-62. PubMed ID: 21835177
[TBL] [Abstract][Full Text] [Related]
8. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
Idris AI; Landao-Bassonga E; Ralston SH
Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
[TBL] [Abstract][Full Text] [Related]
9. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption.
van der Eerden BC; Hoenderop JG; de Vries TJ; Schoenmaker T; Buurman CJ; Uitterlinden AG; Pols HA; Bindels RJ; van Leeuwen JP
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17507-12. PubMed ID: 16291808
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.
Zhang Q; Guo R; Lu Y; Zhao L; Zhou Q; Schwarz EM; Huang J; Chen D; Jin ZG; Boyce BF; Xing L
J Biol Chem; 2008 May; 283(19):13491-9. PubMed ID: 18359770
[TBL] [Abstract][Full Text] [Related]
11. Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway.
Tomomura M; Hasegawa H; Suda N; Sakagami H; Tomomura A
J Biol Chem; 2012 May; 287(22):17963-74. PubMed ID: 22461633
[TBL] [Abstract][Full Text] [Related]
12. Evidence of reciprocal regulation between the high extracellular calcium and RANKL signal transduction pathways in RAW cell derived osteoclasts.
Xu J; Wang C; Han R; Pavlos N; Phan T; Steer JH; Bakker AJ; Joyce DA; Zheng MH
J Cell Physiol; 2005 Feb; 202(2):554-62. PubMed ID: 15389575
[TBL] [Abstract][Full Text] [Related]
13. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
15. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL).
Ang ES; Zhang P; Steer JH; Tan JW; Yip K; Zheng MH; Joyce DA; Xu J
J Cell Physiol; 2007 Sep; 212(3):787-95. PubMed ID: 17477372
[TBL] [Abstract][Full Text] [Related]
16. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
17. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?
Van Bezooijen RL; Papapoulos SE; Löwik CW
Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918
[TBL] [Abstract][Full Text] [Related]
19. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK.
Ang E; Liu Q; Qi M; Liu HG; Yang X; Chen H; Zheng MH; Xu J
J Cell Biochem; 2011 Jan; 112(1):89-97. PubMed ID: 20683903
[TBL] [Abstract][Full Text] [Related]
20. RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts.
Komarova SV; Pilkington MF; Weidema AF; Dixon SJ; Sims SM
J Biol Chem; 2003 Mar; 278(10):8286-93. PubMed ID: 12496256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
